Characteristics of visit-to-visit blood pressure variability in hemodialysis patients. 2019

Yoshifumi Amari, and Satoshi Morimoto, and Takeshi Iida, and Takatomi Yurugi, and Yasuo Oyama, and Naoki Aoyama, and Fumitaka Nakajima, and Satoru Shimizu, and Atsuhiro Ichihara
Department of Endocrinology and Hypertension, Tokyo Women's Medical University, Tokyo, Japan.

Visit-to-visit blood pressure variability (VVBPV) is an independent risk factor for cardiovascular morbidity and mortality in the general population. Hemodialysis (HD) patients have a poor prognosis due to an increased prevalence of cardiovascular disease. Intradialytic hypotension is associated with excess mortality, but whether VVBPV influences mortality is still unclear in HD patients. The present study aimed to investigate the characteristics of VVBPV in these patients. A total of 324 maintenance HD patients, who could be followed for 60 months, were recruited. We used variation independent of the mean (VIM) in pre-dialysis systolic blood pressure (pre-VIM-SBP) as an index of VVBPV. We investigated (1) the reproducibility of pre-VIM-SBP, (2) the relationship between pre-VIM-SBP and background factors, and (3) the association between pre-VIM-SBP and mortality. Pre-VIM-SBP showed significant reproducibility [intraclass correlation, 0.45 (P < 0.001)]. Higher pre-VIM-SBP was associated with less physical activity and worse left ventricular diastolic function. Higher pre-VIM-SBP was associated with a higher rate of cardiovascular deaths independent of other factors. These data suggest that VVBPV in HD patients is reproducible and associated with various background factors. VVBPV is independently correlated with cardiovascular mortality (hazard ratio: 1.166, 95% confidence interval: 1.030-1.320, P = 0.015). Further studies are necessary to confirm the mechanism of increased VVBPV and to clarify whether reducing VVBPV will improve the prognosis for HD patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Yoshifumi Amari, and Satoshi Morimoto, and Takeshi Iida, and Takatomi Yurugi, and Yasuo Oyama, and Naoki Aoyama, and Fumitaka Nakajima, and Satoru Shimizu, and Atsuhiro Ichihara
January 2014, Journal of human hypertension,
Yoshifumi Amari, and Satoshi Morimoto, and Takeshi Iida, and Takatomi Yurugi, and Yasuo Oyama, and Naoki Aoyama, and Fumitaka Nakajima, and Satoru Shimizu, and Atsuhiro Ichihara
November 2017, Kardiologiia,
Yoshifumi Amari, and Satoshi Morimoto, and Takeshi Iida, and Takatomi Yurugi, and Yasuo Oyama, and Naoki Aoyama, and Fumitaka Nakajima, and Satoru Shimizu, and Atsuhiro Ichihara
August 2017, Journal of the American Society of Hypertension : JASH,
Yoshifumi Amari, and Satoshi Morimoto, and Takeshi Iida, and Takatomi Yurugi, and Yasuo Oyama, and Naoki Aoyama, and Fumitaka Nakajima, and Satoru Shimizu, and Atsuhiro Ichihara
January 2014, Journal of clinical hypertension (Greenwich, Conn.),
Yoshifumi Amari, and Satoshi Morimoto, and Takeshi Iida, and Takatomi Yurugi, and Yasuo Oyama, and Naoki Aoyama, and Fumitaka Nakajima, and Satoru Shimizu, and Atsuhiro Ichihara
December 2015, Geriatrics & gerontology international,
Yoshifumi Amari, and Satoshi Morimoto, and Takeshi Iida, and Takatomi Yurugi, and Yasuo Oyama, and Naoki Aoyama, and Fumitaka Nakajima, and Satoru Shimizu, and Atsuhiro Ichihara
January 2024, Studies in health technology and informatics,
Yoshifumi Amari, and Satoshi Morimoto, and Takeshi Iida, and Takatomi Yurugi, and Yasuo Oyama, and Naoki Aoyama, and Fumitaka Nakajima, and Satoru Shimizu, and Atsuhiro Ichihara
January 2014, Alzheimer disease and associated disorders,
Yoshifumi Amari, and Satoshi Morimoto, and Takeshi Iida, and Takatomi Yurugi, and Yasuo Oyama, and Naoki Aoyama, and Fumitaka Nakajima, and Satoru Shimizu, and Atsuhiro Ichihara
February 2015, Journal of clinical hypertension (Greenwich, Conn.),
Yoshifumi Amari, and Satoshi Morimoto, and Takeshi Iida, and Takatomi Yurugi, and Yasuo Oyama, and Naoki Aoyama, and Fumitaka Nakajima, and Satoru Shimizu, and Atsuhiro Ichihara
December 2018, Hypertension research : official journal of the Japanese Society of Hypertension,
Yoshifumi Amari, and Satoshi Morimoto, and Takeshi Iida, and Takatomi Yurugi, and Yasuo Oyama, and Naoki Aoyama, and Fumitaka Nakajima, and Satoru Shimizu, and Atsuhiro Ichihara
April 2015, Renal failure,
Copied contents to your clipboard!